Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ondansetron for prevention of spinal anesthesia-related hypotension during elective cesarean section
IRCT20251120068060N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypotension induced by spinal anesthesia comparing Ondansetron group with Placebo group (2 arms). Primary endpoints: Incidence of hypotension, Systolic blood pressure reduction and 1 more. Started Jan 2026; status: completed.
02
Drugs
ondansetron
03
Conditions
hypotension induced by spinal anesthesia
Beyond the preview
Go deeper on IRCT20251120068060N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251120068060N1.